Share Name Share Symbol Market Type Share ISIN Share Description
Scancell Hldgs LSE:SCLP London Ordinary Share GB00B63D3314 ORD 0.1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  +0.00p +0.00% 13.50p 13.00p 14.00p 13.50p 13.50p 13.50p 5,007 08:00:00
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 0.0 -4.5 -1.4 - 42.13

Scancell Hldgs (SCLP) Latest News

More Scancell Hldgs News
Scancell Hldgs Takeover Rumours

Scancell Hldgs (SCLP) Share Charts

1 Year Scancell Hldgs Chart

1 Year Scancell Hldgs Chart

1 Month Scancell Hldgs Chart

1 Month Scancell Hldgs Chart

Intraday Scancell Hldgs Chart

Intraday Scancell Hldgs Chart

Scancell Hldgs (SCLP) Discussions and Chat

Scancell Hldgs Forums and Chat

Date Time Title Posts
21/2/201812:07Using immunology to fight cancer.13,819
16/10/201619:04Scancell short thread1
16/9/201613:20Could this be the end of cancer?750
22/8/201607:20Question11
16/8/201407:47Using immunology to fight cancer (LTH W/O Rose Tints - Free Speech Thread)161

Add a New Thread

Scancell Hldgs (SCLP) Most Recent Trades

Trade Time Trade Price Trade Size Trade Value Trade Type
11:02:4513.351,206161.00O
10:57:0413.103,801497.93O
2018-02-20 14:07:2313.4015,2372,041.76O
View all Scancell Hldgs trades in real-time

Scancell Hldgs (SCLP) Top Chat Posts

DateSubject
21/2/2018
08:20
Scancell Hldgs Daily Update: Scancell Hldgs is listed in the Pharmaceuticals & Biotechnology sector of the London Stock Exchange with ticker SCLP. The last closing price for Scancell Hldgs was 13.50p.
Scancell Hldgs has a 4 week average price of 9.50p and a 12 week average price of 9.50p.
The 1 year high share price is 16.75p while the 1 year low share price is currently 9.50p.
There are currently 312,058,098 shares in issue and the average daily traded volume is 425,758 shares. The market capitalisation of Scancell Hldgs is £42,127,843.23.
07/2/2018
17:34
tosh 123: At last, a glimmer of sense over on the other place. Wildforce concedes that the shares are too tightly held to be played ! Hurrah ! Hurrah ! Hurrah ! How many times have idiots over there posted that people are trying to manipulate the share price with their posts... hundreds ! The reality is that nothing anyone says on any of these small BB's has any effect on a share price. Nor does the share lend itself to " trading ", it NEVER HAS. Theres far to few shares in open float, and theres absolutely no volatility what so ever, thus anyone that claims the share is being traded, it an absolute moron. Why would a trader mess around with a low priced, low volatility, low volume stock, when the rest of the market is far more attractive ? Some of the stories and rationales coming from the idiots over there, in attempts to justify the shares very poor performance, are laughable. It beggars belief sometimes... The answer to the riddle is staring everyone square in the face, if you choose to ignore it and try to make up your own reasons, you will, as has been seen on many occasions, get hurt.
25/1/2018
14:19
fragma: ONW, What an odd post. "relentless share price predictions " serioulsy. The only relentless share price predictions are made by the relentlessly negative posters. you hardly see any share price ramping going on in this share. You're invested in VAL, why no such comments on the complete and utter unfounded uber ramps going on over there ?
23/1/2018
21:30
tosh123: And with that one post you merely reiterate your complete and utter lack of any understanding what so ever.... You Buffoon ! Firstly Phase III trials, have not only been financed, but they have been completed... Sentiment ? I think not, its down to the FACT that IMM have done exactly what they promised they would do, and completed Phase III. Secondly, as well as completing Phase III trials ( which could not have had any major side effects otherwise the trial would have been stopped ), They have also announced that the recipients of the drug, and indeed the trial coordinators, have asked to EXTEND the treatment for another 6 months.... Sentiment ? I think not, its down to the fact that the trial has apparently been a success. The fact that over the last few years, IMM has gradually mitigated risk is exactly why the share price has risen nearly 400%, not sentiment.... Sentiment is driven by risk, the more comfortable people are that their risks are being reduced, the more the share price increases, the two are directly proportional. rHatton... Unfortunately i think you're right. I would venture that any funding will now be south of the current SP, which is clearly a real kick in the teeth for existing shareholders, especially those who continue to try and support the current levels, by buying more. There is now a real risk that shareholders will be diluted out of existence. Clearly, what we all hope for is someone with deep pockets and credibility to ride over the hillside and provide full financial support, for the next 3 years, however, bearing in mind that the " data room " has been seen by numerous candidates for funding, i think this scenario is becoming more and more unlikely. As i have said before, i will continue to hold " just in case " as if this does make it through the next few years, the potential remains meteoric, but lets not kid ourselves, this is now a longer term investment than it was perceived to be many years ago. I agree that the IP has somewhat increased with the evolution of Modi, but that has not, nor will it, be reflected in the share price until the OBVIOUS RISKS have been mitigated. All the while we have idiots ramping £6 / share, and claiming zero risk etc, he will be the laughing stock of the BB.
23/1/2018
13:34
rhatton: ONW having listened to the recording from the AGM a couple of times it’s clear to me that there was no deal coming which was to provide the cash. It’s was implied as you say that the board as us shareholders would much rather raise money at a higher price. It was again hoped that ‘what maybe coming would have a positive impact on the share price, and then we will go out and raise more money’ (those are almost RGs exact words). Evidently the market was not as impressed as the board thought of but as I said before why would anyone invest and drive the price up to say 20p when there is obviously going to be a discounted fund raising for SCIB1 anyway! The BioNtech tie up is really great for us and I think will yield something but how long we wait is anyone’s guess. The AGM recording also spoke of investors requiring validation so maybe on the CRUK tie up and BioNtech tie up will be enough to gain investment on the validation stand point alone rather than the share price being higher. At a big discount of course.
23/1/2018
13:24
oldnotwise: R Hatton Actually there was an IMPLIED (not specific) "target" of having an event which would provide "cash to spend". This was (IMO) what the market latched onto and was linked with the manifold suggestions that funding was the crucial factor in the short term share price horizon. Thus the "target" I refer to was simply the market's view that there would be a CASH PROVIDING announcement between October 2017 and 10th January 2018. Since that event hasn't happened, that's why I said that I hope it's been delayed rather than not fulfilled. Anyway, you say there was no target, BUT you then state, "I believe there was hope from the board that recent developments would have given the share price a boost." That's PRECISELY the sort of "target" to which I refer.... RG set the share price up with that comment, and let's be honest, it's not the first time that's happened. IMO his statement was rather too specific, because I have sympathy for the view that says he was referring to the CRUK and BioNtech linkups.... but as you say ther's little to do now but sit and wait. ATB
10/1/2018
12:04
the real lozan: rHatton on M F F F = "Frustrating lack of response by the share price yet again. Funding holding everything back here." The WISER, more ASTUTE.. are NOT surprised by the "lack of response by the share price YET again".... NOR are the WISER, more ASTUTE "Frustrated" by such. I posted recently, directing a few posts to = "Newbies and prospective investors here" There have been NONE. For any REAL movement in S P, this will take 'New money' or the transfer of 'existing moneies.... already invested elsewhere....{ Old money if you will} to 'switch' to SCLP. Old money.. is already 'market WISE', wary and 'experienced' NOT to be fooled by the 'trHYPE orchestra, led by the trHYPE CONductor' who have been playing the same 'tune of FAILURE' for 5 years or more. Old money does not care to 'associate' with a share where a 'spiv lout' corrupts other forums, LIES, and makes FALSE CLAIMS... E.G. = " FUNDING is NOT an issue here" . Truth is -Nappy has TOTALLY misread the ability of the 'market' to spot a 'wrong-un' when they see one. Nappy'n'co are the biggest detriment to this share FUNDING REMAINS a MAJOR issue here.{ Even if Nappy CLAIMS it isn't}
30/12/2017
14:46
drdobson1: ONW-Personally thought what a great post. I have been thinking along same lines re Inanaco.Is he a lot cleverer than I have given him credit for. Create the impression of being a long term holder but all the time is he has been trading SCLP-probably only revealed when his ego could not cope with the beating it was taking from the declining share price and he thought I have to be seen as a much better investor/trader than the ASTUTE. On the VAL board he was called a shorter and that he and C7 were part of a boiler room crew.Well I thought that a load of nonsense but perhaps he is a secret trader as you say that stock is a lot more volatile than here. Good traders are often perceived as being devious and only out for themselves and he certainly fits that bill By portraying himself as a self taught science guru he has sought to distract from his game plan which is to destroy investor sentiment and cause maximum bulletin board disharmony. He probably wants to get the SCLP share price to fall so he can buy and trade in fact he may not have much of a holding at all. He is as cunning as a cartload of monkeys and slippery as an eel and has me totally fooled or am I being too kind t9 him. Anyway all have a happy new year
20/12/2017
10:48
rhatton: Agema what was apparent at the AGM was the need to validate the tech to raise the share price and make the company more enticing to investors. The way I see it, two ways actually, has the CRUK partnership provided that validation that a US investor was looking for? Also has the CRUK partnership increased the share price enough to minimise dilution. So in answer to the above I can’t tell regarding the first part but I’d hazardous a guess no for the second part. So maybe they wait longer to go back to the US for the cash whilst trying to pin a deal on moditope to raise the share price? That is a possibility, but again means more delays to SCIB1 trial. At least 2019 will mark SCIB2 into trails, that is certain. But also a long way away!
27/11/2017
17:42
inanaco: Yes just pointing out that twitter is way overvalued, If the current statements from RNS from the likes of Keith Flaherty etc have had little impact via RNS , i cannot see how Luke The man with twitter could influence. Its my opinion and till we see the share price react to any event on twitter, its all hypothetical. Gooosed blind post, how childish !! in reply indeed Lukes tweet to RG .. generated what exactly to the share price ??? and indeed, did his followers suddenly start buying Scancell ? The point i am making the share price has never reacted to twitter. It reacts to RNS and direct publishing to investors via the Times etc.
23/11/2017
16:00
inanaco: ""if you make a statement that i cannot reason against then your statement becomes the lead policy which i then support "" yes because most of the intense discussion are on the science that impact IP value """There are plenty. Here's just one: share price down from 60p to 12p. Isn't that a negative? I make it negative 48p."""" That's sentiment has the science stood still in all that time, ? ""the Shareprice is not relevant as all i am trying to show is it's cheap relative to the IP.<<br /> Two fatal flaws in one sentence: 1) How on earth can you say the share price isn't relevant??!! It is very relevant if you have invested and need to sell.""" You have now added a third party ie somebody that needs to sell, that is not my position. """It is relevant to how easy it is for SCLP to raise new funds and at what price those funds are raised and therefore relevant to the amount of dilution of our investment.""" Very true, But like you have done, you can then look at the shares in issue and assess the likely outcome of capital growth based on the resultant influx of cash and how the science develops from that Dilution so has a result on both sides of the equation Ie A bigger increase in capital growth than was forecast without that expenditure. """ all i am trying to show is it's cheap relative to the IP.<<br /> Well you haven't! """ I have but maybe you have not understood the years of comparing and understanding of the science of others with wildforce allowed us to pretty well place Scancell into the market place and place reasoned value to the IP """" lozan/Tosh, Mr W cannot explain why the IP has a lower value to the share price <<br /> The IP has a lower value to the SP? Are you saying the IP is not worth 12p? """ actually the buying of the share by Loz at 47p and selling at 53p would indicate Loz buying at the level was cheap and selling at 53p produced a true value event. to then argue its only worth 12p with that evidence would be difficult ... but Loz would have to show comparative value to the IP .. being 12p .. which i suspect would be impossible """not a point worth discussing as No conclusion will be ever drawn from it as its not linked to IP only market sentiment on any particular day ...<<br /> You have a point, why worry about a share price of 12.3 when it could easily be 12.5 tomorrow."" I am not worried about the share price, i already feel the value way exceeds this level, and indeed the Board of Scancell accept that, hence they want to raise the big amounts not based on share price but IP .. however they will always have the fall back position of market priced cash raising which again is Not Ip priced cash raising like a deal """thus all the posts can be dismissed as not relevant, <<br /> In YOUR opinion, which here does not command a very high level of respect"""" then show me posts that you feel are of High Value that i have missed, like i said I debate for my own investment position ..I defend Scancell because I am invested not because your invested,
Scancell Hldgs share price data is direct from the London Stock Exchange
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:42 V: D:20180221 13:14:53